Search details
1.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35068173
2.
Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study.
Pathologica
; 114(4): 278-287, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-36083243
3.
Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations.
Int J Mol Sci
; 22(23)2021 Nov 28.
Article
in English
| MEDLINE | ID: mdl-34884672
4.
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Br J Cancer
; 123(1): 26-32, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32346071
5.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32474768
6.
Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
Br J Cancer
; 119(11): 1326-1331, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30405211
7.
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Tumour Biol
; 40(11): 1010428318815047, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30486741
8.
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Br J Cancer
; 125(2): 306, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-34012035
9.
'Turban-like' skull metastasis from pulmonary adenocarcinoma.
Thorax
; 72(8): 767-768, 2017 08.
Article
in English
| MEDLINE | ID: mdl-27913767
10.
Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how "large" your diagnostic criteria are.
Eur Respir J
; 50(4)2017 10.
Article
in English
| MEDLINE | ID: mdl-29074547
11.
Thyroid function impairment after chemo-immunotherapy for advanced NSCLC: a single institutional retrospective report.
Immunotherapy
; 2022 Apr 13.
Article
in English
| MEDLINE | ID: mdl-35416048
12.
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres.
Life (Basel)
; 12(8)2022 Jul 29.
Article
in English
| MEDLINE | ID: mdl-36013328
13.
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.
Cancers (Basel)
; 14(8)2022 Apr 16.
Article
in English
| MEDLINE | ID: mdl-35454926
14.
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.
Clin Lung Cancer
; 23(7): e478-e488, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36002369
15.
Pembrolizumab rechallenge in squamous non-small-cell lung cancer and HIV-positivity: a case report.
Immunotherapy
; 13(4): 277-281, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33249929
16.
Body composition and inflammation impact in non-small-cell lung cancer patients treated by first-line immunotherapy.
Immunotherapy
; 13(18): 1501-1519, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34670403
17.
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy.
Clin Nutr ESPEN
; 43: 64-75, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34024567
18.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Eur J Cancer
; 150: 224-231, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33934059
19.
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.
J Immunother Cancer
; 9(4)2021 04.
Article
in English
| MEDLINE | ID: mdl-33827906
20.
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality.
Crit Rev Oncol Hematol
; 145: 102836, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31918216